This article is more than 5 years old. Information may no longer be current.

Stanmore receives CE mark for silver modular implant technology

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Stanmore Implants announced that its silver-treated modular implant system has received an European CE mark. The silver-treated massive endoprosthesis tumor system (METS) technology, which can be manufactured for several orthopedic skeletal locations, including the femur, tibia, knee, pelvis and humerus, greatly reduces the risk for infection in the patient.

“With infection being a major burden on the health care system and often leading to avoidable amputations, we are delighted to secure approval for our silver treated METS system,” Brian Steer, the executive chairman of Stanmore, stated in a company press release. “There is increasing evidence to support silver’s antimicrobial properties, and incorporating it into our METS system puts Stanmore in a strong competitive position.”